← Back to patent-cliff list
CAS 88-05-1
2,4,6-trimethylaniline
Codes: RPL-554-003
Application context (from source-drug indications)
Chronic obstructive pulmonary diseaseEnsifentrine冠状病毒感染EnsifentrineCOVID-19EnsifentrineCystic fibrosisEnsifentrineAsthmaEnsifentrineInflammatory diseaseEnsifentrine
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Ensifentrine | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(3,4-dimethoxyphenethyl)pyrimidine-2,4,6(1H,3H,5H)-trione→2-chloro-9,10-dimethoxy-6,7-dihydro-4H-pyrimido[6,1-a]isoquinolin-4-one→2,4,6-trimethylaniline→(E)-2-(mesitylimino)-9,10-dimethoxy-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one→2-(2-bromoethyl)isoindoline-1,3-dione→(E)-2-(2-(2-(mesitylimino)-9,10-dimethoxy-4-oxo-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl)ethyl)isoindoline-1,3-dione→(E)-3-(2-aminoethyl)-2-(mesitylimino)-9,10-dimethoxy-2,3,6,7-tetrahydro-4H-pyrimido[6,1-a]isoquinolin-4-one
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 2,4,6-Trimethylaniline Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.